Patents Examined by Mina Haghighatian
  • Patent number: 11905304
    Abstract: Agricultural products, such as pesticides, plant growth regulators, fungicides, herbicides, and insecticides, may be formulated to include one or more surfactants, from one or more surfactant classes, such as siloxane derivatives of amino acids that have surface-active properties.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: February 20, 2024
    Assignee: AdvanSix Resins & Chemicals LLC
    Inventor: Edward Asirvatham
  • Patent number: 11896571
    Abstract: The invention provides methods for increasing oral osteogenesis using LXA4 and its analogs. Methods are also provided for treating or preventing oral disorders that would benefit from increased oral osteogenesis using LXA4 and its analogs.
    Type: Grant
    Filed: October 7, 2019
    Date of Patent: February 13, 2024
    Assignee: Forsyth Dental Infirmary for Children
    Inventors: Thomas E. Van Dyke, Hatice Hasturk, Alpdogan Kantarci
  • Patent number: 11890381
    Abstract: A present invention relates to a natural lubricant composition, a tablet comprising a natural lubricant composition and a preparation method thereof. The Natural Lubricant composition for a tablet comprises an active lubricant ingredient selected from a corn flour, a corn starch, and an arrowroot flour. The Natural Lubricant composition for a tablet also comprises a natural oil.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: February 6, 2024
    Assignee: NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
    Inventor: Ravleen Singh Khurana
  • Patent number: 11889831
    Abstract: An aqueous slurry composition containing microcapsules dispersed in an aqueous medium. The microcapsules contain an ionic acrylate copolymer shell encapsulating an oily medium. Upon drying, the microcapsules release the oily medium. The slurry is useful in delivering a variety of water-insoluble substances via an aqueous medium including cosmetic or agricultural agents.
    Type: Grant
    Filed: October 17, 2019
    Date of Patent: February 6, 2024
    Assignees: ENCAPSYS, LLC, IPS STRUCTURAL ADHESIVES, INC., IPS CORPORATION, WATERTITE PRODUCTS, INC., WELD-ON ADHESIVES, INC., IPS ADHESIVES LLC
    Inventor: Todd Arlin Schwantes
  • Patent number: 11882834
    Abstract: Compounds of the formula (I), (I) wherein the substituents are as defined in claim 1, useful as pesticides, and especially fungicides.
    Type: Grant
    Filed: November 27, 2018
    Date of Patent: January 30, 2024
    Assignee: SYNGENTA PARTICIPATIONS AG
    Inventors: Martin Pouliot, Stefano Rendine
  • Patent number: 11884781
    Abstract: The present invention relates to supramolecular biomedical polymers comprising quadruple hydrogen bonding units and to a process for preparing such a supramolecular biomedical polymer and porous biomedical implants thereof. The supramolecular biomedical polymers are particularly suitable for the production of porous biomedical implants that need high strength, elasticity, durability, and slow biodegradation, e.g. medical implants for living tissue regeneration within a mammal, such as the treatment of cardio-vascular diseases, medical prolapses, and hernias.
    Type: Grant
    Filed: May 19, 2020
    Date of Patent: January 30, 2024
    Assignee: SUPRAPOLIX B.V.
    Inventors: Tristan Mes, Anton Willem Bosman, Joris Wilhelmus Peeters, Henricus Marie Janssen
  • Patent number: 11883528
    Abstract: A pharmaceutical composition for administering directly to the pulmonary tract of a subject includes a salt of triiodothyronine and a pharmaceutically acceptable buffer, adjusted to a pH of 5.5-8.5. The composition can be administered prophylactically or therapeutically to a subject to treat lung inflammation or pulmonary edema.
    Type: Grant
    Filed: August 23, 2022
    Date of Patent: January 30, 2024
    Assignee: Regents of the University of Minnesota
    Inventors: David H. Ingbar, Timothy P. Rich, Robert J. Schumacher, Jianxun Lei, Maneesh Bhargava
  • Patent number: 11865206
    Abstract: The present invention relates to a ready-to-use solution of carmustine that does not require dissolution or dilution of the carmustine prior to addition to saline and dextrose parenteral solutions. In particular, the invention relates to a stable liquid pharmaceutical composition containing carmustine in the form of ready-to-use solution and method for preparing the same.
    Type: Grant
    Filed: December 28, 2022
    Date of Patent: January 9, 2024
    Assignee: EMCURE PHARMACEUTICALS LTD
    Inventors: Sougata Pramanick, Aasiya Aslam Burhan, Mukund Keshav Gurjar, Hiren Pravinbhai Patel, Deepak Pragjibhai Gondaliya
  • Patent number: 11850292
    Abstract: A composition comprising microcapsules functionalized with polymerizable functional groups on the surface of said microcapsules wherein the functional groups form covalent bonds with monomers in the continuous phase to enhance the mechanical properties of the composition.
    Type: Grant
    Filed: July 29, 2022
    Date of Patent: December 26, 2023
    Assignee: Premier Dental Products Company
    Inventors: Stephen M. Gross, William A. McHale, Mark A. Latta
  • Patent number: 11851707
    Abstract: A method of predicting the development of chronic lung allograft dysfunction (CLAD) in lung transplant patients using N-myc-interactor (NMI) as a biomarker and associated treatment thereof is presented. Also presented is a method of reducing the risk of CLAD by administering a therapeutic agent capable of increasing NMI in the patient. NMI is a critical regulator of epithelial-to-mesenchymal transition (EMT) and an important precursor to development of CLAD. NMI expression is reduced in CLAD patients and can be used as an early diagnostic biomarker to predict the development of CLAD. NMI can also be used as a drug target for a therapeutic to increase expression of NMI and treat chronic lung disease such as CLAD. Therapeutics comprising NMI protein or NMI gene can be used as potential treatments for chronic lung diseases such as CLAD.
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: December 26, 2023
    Assignee: University of South Florida
    Inventors: Nirmal S. Sharma, Mudassir Banday, Andreas Seyfang
  • Patent number: 11850294
    Abstract: A microcapsule composition comprising at least one polymer substantially disposed as a semipermeable shell around an aqueous buffered solution and at least one agent, wherein the agent permeates the shell, and wherein the composition is suitable for delivery to a mammal.
    Type: Grant
    Filed: November 23, 2021
    Date of Patent: December 26, 2023
    Assignee: Premier Dental Products Company
    Inventors: Mark A. Latta, Stephen M. Gross, William A McHale
  • Patent number: 11839207
    Abstract: A formulation is especially suited as one or more of an insecticide, anti-viral, anti-bacterial, anti-fungicide as well as one that acts as a fertilizer and/or an enhancement to a fertilizer when the formulation is coated thereon. The formulation can be used to treat plants for pest control and/or fertilization or other areas in that require a viral, fungal, and/or bacterial treatment.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: December 12, 2023
    Inventor: Jerry R. Bond
  • Patent number: 11819488
    Abstract: The present invention is directed to nanosuspensions of salsalate and methods of making and using such compositions.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: November 21, 2023
    Assignee: RHNanoPharma
    Inventors: Joel Ross, Izhar Hasan
  • Patent number: 11812741
    Abstract: A method for producing a biocide from a hypochlorite oxidant and an ammonium salt is provided. The method focuses on preventing and/or reducing the presence of excess ammonium. The molar ratio of ammonium to hypochlorite is less than 1:1. In a preferred embodiment, the method includes monitoring the conductivity of the biocide to optimize the ratio between the hypochlorite oxidant and the ammonium salt. The optimum ratio is that at which the conductivity has a local maximum.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: November 14, 2023
    Assignee: A.Y. LABORATORIES LTD.
    Inventor: Ayala Barak
  • Patent number: 11813360
    Abstract: The present invention concerns carrier particles suitable for use in dry powder formulations for inhalation. The invention also relates to processes for their preparation by spray-congealing.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: November 14, 2023
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Tomaso Guidi, Amrit Paudel, Sarah Elizabeth Zellnitz, Joana Filipa Fernandes Teixeira Pinto
  • Patent number: 11802241
    Abstract: Methods of increasing soil water content are described. The methods may include applying a soil enhancement agent to the soil, where the soil enhancement agent includes one or both of (i) lactobionic acid and (ii) at least one salt of lactobionic acid. Treated soils with increased soil water content are also described. The treated soils may include a soil enhancement agent absorbed into the soil. The soil enhancement agent may include at least one salt of a lactobionic acid. Cations from the at least one salt of a lactobionic acid may aggregate at least a portion of the particles in the soil.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: October 31, 2023
    Assignee: Leprino Foods Company
    Inventor: Richard K. Merrill
  • Patent number: 11801239
    Abstract: A powder injection of a donepezil semi palmoxiric acid salt, a composition containing the same and a preparation method therefor. The powder injection contains donepezil semi palmoxiric acid salt crystals having an average particle size of 2-52 ?m.
    Type: Grant
    Filed: November 10, 2021
    Date of Patent: October 31, 2023
    Assignees: Shanghai Synergy Pharmaceutical Sciences Co., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd.
    Inventors: Jian Ge, Yunfei Li, Lihong Lin, Dengxue Sun, Jiamiao Wang, Yijin Wang, Zhiyun Wang
  • Patent number: 11800869
    Abstract: 6-oxo-1,4,5,6 tetrahydropyridazine-3-carboxylic acid or its salts or 1-methyl 6-oxo-1,4,5,6-tetrahydropyridizin-3-carboxylic acid or its salts, to plants can cause an increase in parameters such as germination, seedling emergence, growth, drought tolerance and recovery, yield, rhizobia induced root nodulation as compared to untreated wild type plants. 1-Methyl 6-oxo-1,4,5,6 tetrahydropyridazine-3-carboxylic acid or its salts is chemically the simplest 1-alkyl 6-oxo-1,4,5,6-tetrahydropyridazine-3-carboxylic acid and as such is an example showing the effectiveness of a 1-alkyl 6-oxo-1,4,5,6 tetrahydropyridazine-3-carboxylic acid. Higher series derivatives such as 1-alkyl 6-oxo-1,4,5,6 tetrahydropyridazine-3-carboxylic acids also induce beneficial effects on treated plants.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: October 31, 2023
    Assignee: Advanced Crop Chem LLP
    Inventors: Pat J Unkefer, Rodolfo Martinez, Nigel Grech, John Haywood
  • Patent number: 11786580
    Abstract: In certain embodiments, this disclosure relates to VIP and VIP agonists, optionally conjugated to nanoparticles, for use in methods of treating inflammatory T cell-mediated diseases or conditions, e.g., treating or preventing GvHD. In certain embodiments, this disclosure relates to methods of pulmonary administration of VIP and VIP agonists, optionally conjugated to nanoparticles. In certain embodiments, this disclosure contemplates nanoparticles disclosed herein.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: October 17, 2023
    Assignee: Emory University
    Inventors: Giacomo Waller, Yiwen Li, Edmund Waller
  • Patent number: 11786763
    Abstract: The invention aims to provide a crosslinked polymer having an excellent liquid absorption capacity and sufficient gel-pulverizability. The invention relates to a N-vinyl lactam-based crosslinked polymer including: a structural unit derived from a N-vinyl lactam-based monomer; and a structural unit derived from triallyl cyanurate, the N-vinyl lactam-based crosslinked polymer containing the structural unit derived from triallyl cyanurate in a ratio of 0.12 to 0.48 mol % to 100 mol % of all structural units.
    Type: Grant
    Filed: July 7, 2017
    Date of Patent: October 17, 2023
    Assignee: Nippon Shokubai Co., Ltd.
    Inventors: Yui Ikemoto, Kazuhiro Okamura